Establish a reference standard for HIV Screening with the use of ELISA from finger stick blood sampled on DBS filter paper
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2017 - 2017
Project Lead
Dr. Savitha Nagaraj, Dr. Tony Raj
Authors
Dr. Savitha Nagaraj, Dr. Tony Raj
Project Status
completed
Project Type
Swasti Health Resource Center, Bangalore